The study examining the GCC Oncology/Cancer Drugs Market is the recent report documented by Markntel Advisors, which is purely biased in terms of factual statistics and aims to deliver the interested stakeholders to come forward and gather the most credible information produced by our marketing analysts via investigating every viable secondary source of information primarily accessible through several different websites.
To simplify the market tractions and offer the best possible projections for the next five years, our team brings the best to the table compared to the other competitors in the research market. Moreover, it also features a wide range of significant elements, such as substantial drivers, restrictions, opportunities, vital needs, setbacks, new developments, country wise divide, etc., which have been successfully altered in this research as per the rising fluctuations.
Sample PDF of This Study Report – Download Now
|Study Period||Historical Data: 2018-21|
|Base Year: 2022|
|Forecast Period: 2023-28|
|Country Covered||Saudi Arabia, The UAE, Qatar, Kuwait, Bahrain, Oman|
|Key Companies Profiled||Hoffmann-La Roche Ltd., Johnson & Johnson Middle East FZ LLC, Pfizer International Corporation, Merck Serono Middle East FZ-Ltd., AbbVie Biopharmaceuticals GmbH, AstraZeneca Gulf FZ LLC, Bayer Middle East FZE, Amgen, Inc., Astellas MENA/SSA, Others|
|Unit Denominations||USD Million/Billion|
Report Table of Content
- Market Segmentation
- Product Definition
- Research Process
- Executive Summary
- GCC Oncology/Cancer Drugs Market Trends & Insights
- GCC Oncology/Cancer Drugs Market Dynamics
- GCC Oncology/Cancer Drugs Market Regulations & Policies
- GCC Oncology/Cancer Drugs Market Hotspots & Opportunities
- GCC Oncology/Cancer Drugs Market Outlook, 2018-2028F
Major Topics We Covered in this Study Report
- GCC Oncology/Cancer Drugs Market Expensing Till 2028 –
The GCC Oncology/Cancer Drugs Market is projected to grow at a considerable CAGR during the forecast period, i.e., 2023-28. This is due to the rising incidences of patients diagnosed with cancer in the nations like the UAE, Saudi Arabia, Kuwait, etc., and the surging initiative to reduce the number of deaths due to cancer. As per the World Health Organization, a total of around 21.4% of breast cancer cases were reported in 2020 in the UAE, whereas the same around 14.5% of colorectal cancer, and nearly 12.5% of prostate cancer were reported among men in the country.
- Industry Driving Factor –
The GCC nations have been witnessing a massive surge in several types of cancer cases including lung cancer, breast cancer, colorectal cancer, prostate cancer, etc. The prominent factor behind the increasing cases of lung cancer in the GCC nations remains the habit of tobacco smoking among the men population. The smoking prevalence has been subsequently leading to a large number of lung cancer cases mainly in Saudi Arabia, Bahrain, and Oman. For instance, in 2020, around 6% male of Saudi Arabia were diagnosed with lung cancer, as per the World Health Organization. Thus, the growing prevalence of different types of cancers among the GCC population would facilitate the requirement for oncology/cancer drugs in the forthcoming period.
- Available Growth Opportunity in the Market –
The GCC nations have been witnessing a massive surge in several types of cancer cases including lung cancer, breast cancer, colorectal cancer, prostate cancer, etc. The prominent factor behind the increasing cases of lung cancer in the GCC nations remains the habit of tobacco smoking among the men population. The smoking prevalence has been subsequently leading to a large number of lung cancer cases mainly in Saudi Arabia, Bahrain, and Oman. For instance, in 2020, around 6% of males in Saudi Arabia were diagnosed with lung cancer, as per the World Health Organization. Thus, the growing prevalence of different types of cancers among the GCC population would facilitate the requirement for oncology/cancer drugs in the forthcoming period.
- Geographical Dividation and Leading Type –
On the Geographical front, the GCC Oncology/Cancer Drugs market is divided across Saudi Arabia, The UAE, Qatar, Kuwait, Bahrain, and Oman country. Among all the nations, the UAE is expected to be a hotspot for the demand for oncology/cancer drugs in the forecast years, owing to the massive surge in the cases of breast cancer among the female population of the country. In addition, the malignancy of breast cancer cases in the UAE has led to the launch of several awareness campaigns for the detection of breast cancer among the female population.
Inquiry More or Want to Discuss Further while Talking with our Analyst – Schedule A Call With Our Analysis Now For Free
GCC Oncology/Cancer Drugs Market Fragmentation
The objective of fragmenting the report on the basis of country is to examine and list down the industry’s key players and other significant aspects of different areas and their contributions in thriving the substantial progress of the market. Hence, it facilitates the stakeholders to perform in-depth research and execute a rigorous strategy for their businesses via the help of the research paper published by the talented team of Markntel Advisors. Other than geographical division, the industry segmentations bifurcate across the following segments:
- Targeted Therapy
- Hormonal Therapy
- Breast Cancer
- Lung Cancer
- Kidney Cancer
- Liver cancer
- Ovarian Cancer
- Prostate Cancer
- Skin Cancer
- Pancreatic Cancer
- Blood Cancer
Competitive Analysis of the Key Players
The following section is notably dedicated to the industry giants and their significant contributions to propelling the GCC Oncology/Cancer Drugs market in terms of revenues, growth, employment opportunities, and several others. It offers the stakeholders, along with the key investors, the to make a move by holistically investigating their strategies and the success that they have achieved before the projected period. Moreover, their recent developments, innovations, implementations, and revenue models are thoroughly labelled in the study.
- Hoffmann-La Roche Ltd.
- Johnson & Johnson Middle East FZ LLC
- Pfizer International Corporation
- Merck Serono Middle East FZ-Ltd.
- AbbVie Biopharmaceuticals GmbH
- AstraZeneca Gulf FZ LLC
- Bayer Middle East FZE
- Amgen, Inc.
- Astellas MENA/SSA
Your Success is Our Motive. Get Your Reports Customized in No Time.
The diverse range of research reports offered by the young, dynamic, and dedicated team of Markntel Advisors ensures that the success of their clients is their prime motive. Hence, comprising the needs ultimately compromises success, which is unquestionably unacceptable. Therefore, to make a difference and deliver in-depth research with complete customization as per the client’s requirements is what we aim and work for.
To Get the Benefit of Our Report Customization Service, Sent Your Request Here – https://www.marknteladvisors.com/query/request-customization/gcc-oncology-cancer-drugs-market.html
Related Reports –
About MarkNtel Advisors
We are a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Our Contact Details –
Phone – +1 628 895 8081, +91 120 4278433
Follow Us – Twitter, LinkedIn, Facebook, Pinterest
Press Release – www.marknteladvisors.com/press-release